$TLRY

Tilray Brands, Inc. Q1 2027: Revenue $257.1M, EPS $(0.32) — 10-Q Summary

Tilray Brands reported Q1 2027 revenue of $257.1M, up 23% YoY, but a net loss of $43.1M and EPS of $(0.32). Growth was driven by beverage expansion and EMEA strength, while cannabis revenue declined 13%. The company attributed changes to the BrewDog acquisition and strategic shifts.

Original reporting
Published Oct 8, 2026, 9:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 8, 2026, 9:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Tilray Brands, Inc. Q1 2027: Revenue $257.1M, EPS $(0.32) — 10-Q Summary — source image
Decision brief

The 30-second read

$TLRYBearishMed
01

Why it matters

The earnings miss and widened loss are likely to trigger a sell‑off in TLRY and may influence sentiment toward peer cannabis companies.

02

Market read

New earnings numbers introduce fresh risk for TLRY and may affect the broader cannabis sector.

03

What to watch

Higher‑margin flower redirection to international markets may improve future profitability.

Relevance 8/10Novelty 8/10Timing: post‑market today

Background

Tilray Brands filed its Form 10‑Q for the quarter ended Aug 31 2026, providing the first public disclosure of its latest earnings.

Company-level read

Ticker impact

$TLRYBearishHigh confidence
Context

Tilray reported Q1 results with revenue $257.1M, net loss $43.1M and diluted EPS -$0.32.

Expected impact

likely downside as the market prices in the larger loss

Evidence & confidence

The loss is substantially larger than the prior year‑ago quarter, and revenue growth is driven by non‑core beverage segment.

Market effects

Cannabis sector may face broader pressure from Tilray's widening loss.

North American cannabis stocks could see short‑term weakness.

Limited to investors tracking the global cannabis industry.

Counterpoint

The beverage expansion could signal a new growth engine that offsets cannabis headwinds.

Key entities

  • Tilray Brands, Inc.

    US‑listed cannabis and beverage company reporting Q1 2027 results.

Related articles

$TLRYMedAI 8/10

Tilray Brands Q1 Earnings Call Highlights

Tilray Brands reported Q1 cannabis gross margin rose to 39% from 36%, driven by operational efficiencies and Portugal facility use. Beverage revenue surged 82% YoY to $101.5M, with BrewDog turning profitable. Distribution revenue grew 14% to $84.3M. The company expects fiscal 2027 cannabis production to exceed 40 metric tons and has a multiyear deal with Carlsberg Group for U.S. distribution starting 2027. Tilray ended Q1 with $221M in cash and marketable securities.

$TLRYMed

Tilray Brands (TLRY) Shares Slip Premarket After Q1 Revenue Miss

Tilray Brands (TLRY) reported Q1 revenue of $257.2M, up 23% YoY but below estimates by $9.7M. Cannabis revenue declined 13%, while beverage and distribution segments grew. The company posted a net loss of $3.0M but beat adjusted EPS estimates by $0.16. Tilray's P/S ratio is 0.45, below historical and industry averages, reflecting market skepticism about future growth.